The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.
about
Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain InhibitorsDual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsAntiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammationBromodomain and Extra-Terminal Protein Inhibition Attenuates Neutrophil-dominant Allergic Airway Disease.The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.BET inhibitors: a novel epigenetic approach.OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development.Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the RescueBromodomain inhibitors and cancer therapy: From structures to applications.Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors.The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.BRD4 inhibitor IBET upregulates p27kip/cip protein stability in neuroendocrine tumor cells.
P2860
Q27701027-8659888D-6197-4BFA-A298-F1B6B92BFBFAQ28276260-8087546E-9790-46F3-A23D-91F66266FED0Q37161413-84B55D49-5DED-4851-B960-1BDBEFE93198Q37663035-5B825879-1CA7-4E13-AA3E-6D6E64768FE9Q38260084-76EE18F0-5863-4D3C-A3CD-642467C218B8Q38609772-AD4E188A-22F3-4D14-B7FF-B11682A39D18Q38759279-572CD1DF-6CA4-4843-9BFC-B809110D6CE3Q38771703-179E7F8F-0233-4C31-BAA4-C206AA72737BQ38850598-EAAFBF57-A64B-484C-B9FE-FC407945D963Q39027056-A41D4355-E050-4570-87B5-5879FF750D7EQ41098457-BE204893-474F-4030-99C5-031F48112450Q47103987-0D4E5816-080F-492B-9C33-84147AB52739Q51102697-620DBAE9-D94D-4976-8BA4-EFDB80DF28EC
P2860
The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@ast
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@en
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@nl
type
label
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@ast
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@en
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@nl
prefLabel
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@ast
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@en
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@nl
P2093
P2860
P356
P1476
The bromodomain and extra-term ...... n human neuroendocrine tumors.
@en
P2093
A J Levine
C R Harris
S V Laddha
P2860
P356
10.1038/CDDIS.2014.396
P577
2014-10-09T00:00:00Z